BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17156825)

  • 1. Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants.
    Devreese KM
    Thromb Res; 2007; 120(3):427-38. PubMed ID: 17156825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of sensitivity and specificity of confirmatory assays for lupus anticoagulant (LA) detection].
    Imoto K; Yasumuro Y; Taki M; Suzuki Y; Akatu S; Tajima C; Ichikawa Y
    Rinsho Byori; 1996 Aug; 44(8):797-801. PubMed ID: 8816068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
    Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
    Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
    Grypiotis P; Ruffatti A; Pengo V; Tonello M; Biasiolo A; Zamboni D; Cavazzana A; Todesco S
    J Clin Lab Anal; 2006; 20(1):15-8. PubMed ID: 16470527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of silica clotting time for detection of lupus anticoagulants].
    Lee HR; Kim JE; Ha SH; Kim HK; Park S; Cho HI
    Korean J Lab Med; 2009 Dec; 29(6):497-504. PubMed ID: 20046079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of silica clotting time method for lupus anticoagulant in a clinical population with various symptoms of antiphospholipid syndrome.
    Averina M; Johannesen S; Brox J
    Lupus; 2016 Apr; 25(4):418-22. PubMed ID: 26612052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis of lupus anticoagulants--effect of residual platelets in plasma, assessed by Staclot LA and silica clotting time.
    Chantarangkul V; Tripodi A; Clerici M; Bressi C; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):854-8. PubMed ID: 12038789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
    Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
    Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-mixing test to detect lupus anticoagulant for diagnosis of antiphospholipid syndrome].
    Ieko M; Naito S; Yoshida M
    Rinsho Byori; 2009 Oct; 57(10):990-8. PubMed ID: 19928497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimisation of lupus anticoagulant tests: should test samples always be mixed with normal plasma?
    Pennings MT; De Groot PG; Meijers JC; Huisman A; Derksen RH; Urbanus RT
    Thromb Haemost; 2014 Oct; 112(4):736-42. PubMed ID: 25008787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.
    Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G
    Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical diagnosis of thrombosis and blood coagulation tests].
    Watanabe K
    Rinsho Byori; 1998 Mar; 46(3):235-44. PubMed ID: 9564763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lupus anticoagulant: a multicenter study for a standardized and harmonized reporting.
    Poz A; Pradella P; Azzarini G; Santarossa L; Bardin C; Zardo L; Giacomello R
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):176-84. PubMed ID: 26366826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence of false negative screening for lupus anticoagulants.
    Moore GW; Henley A; Greenwood CK; Rangarajan S
    Thromb Res; 2008; 121(4):477-84. PubMed ID: 17602725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.